CN Stock MarketDetailed Quotes

Zhejiang Haisen Pharmaceutical (001367)

Watchlist
  • 23.42
  • -0.69-2.86%
Market Closed May 15 15:00 CST
3.57BMarket Cap26.70P/E (TTM)

Zhejiang Haisen Pharmaceutical (001367) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-9.53%107.19M
12.88%532.26M
12.13%358.87M
14.93%242.09M
2.32%118.48M
18.63%471.51M
13.02%320.04M
8.93%210.64M
8.27%115.8M
-5.99%397.45M
Operating revenue
-9.53%107.19M
12.88%532.26M
12.13%358.87M
14.93%242.09M
2.32%118.48M
18.63%471.51M
13.02%320.04M
8.93%210.64M
8.27%115.8M
-5.99%397.45M
Other operating revenue
----
-39.12%587.92K
----
-5.82%407.79K
----
-17.36%965.74K
----
-53.80%432.99K
----
-28.82%1.17M
Total operating cost
-7.92%76.95M
14.47%381.2M
17.47%259.59M
18.86%172.7M
7.96%83.57M
19.91%333.03M
9.41%220.99M
3.15%145.3M
-0.08%77.41M
-8.61%277.74M
Operating cost
-15.97%55.54M
4.92%289.55M
4.07%195.28M
8.00%134.3M
-6.26%66.1M
17.84%275.96M
10.57%187.65M
5.40%124.36M
4.66%70.51M
-11.57%234.18M
Operating tax surcharges
33.94%1.36M
5.08%4.58M
7.65%3.6M
2.81%2.32M
13.61%1.01M
4.75%4.36M
16.24%3.35M
7.46%2.25M
17.00%892.61K
95.38%4.16M
Operating expense
11.60%2.86M
31.17%16.2M
28.98%11.18M
12.18%6.74M
49.46%2.56M
18.06%12.35M
8.26%8.67M
14.19%6M
-10.76%1.71M
4.22%10.46M
Administration expense
3.70%7.27M
20.60%37.03M
41.09%25.68M
29.34%15.49M
38.25%7.01M
17.96%30.71M
-9.05%18.2M
-13.62%11.98M
5.29%5.07M
14.53%26.03M
Financial expense
120.56%525.26K
72.31%-5.02M
70.66%-4.31M
64.60%-3.85M
49.55%-2.55M
-13.74%-18.13M
-33.27%-14.69M
-76.41%-10.88M
-1,133.71%-5.06M
-37.70%-15.94M
-Interest expense (Financial expense)
-9.69%76.7K
-7.40%346.05K
-7.15%259.16K
-6.36%172.79K
-7.94%84.93K
1,000.55%373.72K
986.72%279.12K
467.99%184.52K
467.99%92.26K
-49.99%33.96K
-Interest Income (Financial expense)
50.69%-946.11K
63.13%-5.68M
69.90%-4M
66.44%-3.08M
53.40%-1.92M
-0.75%-15.41M
-32.28%-13.28M
-68.25%-9.17M
-213.59%-4.12M
-330.91%-15.3M
Research and development
-0.43%9.4M
39.89%38.86M
57.96%28.17M
52.83%17.71M
120.63%9.44M
47.44%27.78M
43.61%17.83M
48.10%11.59M
42.58%4.28M
19.50%18.84M
Credit Impairment Loss
2,840.98%1.33M
-2,610.71%-2.75M
-170.86%-566.72K
-205.41%-448.21K
182.19%45.09K
76.25%-101.55K
50,837.53%799.76K
151.35%425.21K
90.25%-54.86K
44.38%-427.52K
Asset Impairment Loss
-341.27%-60.71K
80.24%-698.85K
32.50%-400.2K
52.91%-256.9K
95.52%-13.76K
-45.07%-3.54M
-21.81%-592.85K
-32.50%-545.51K
---306.99K
-107.81%-2.44M
Other net revenue
219.42%2.88M
62.49%5.79M
13.28%2.92M
-58.51%843.08K
27.71%902.75K
57.62%3.56M
19.76%2.58M
309.42%2.03M
240.24%706.85K
-18.50%2.26M
Fair value change income
----
--1.7M
----
----
----
----
----
----
----
----
Invest income
496.04%1.27M
67.23%5.02M
1,426.94%2.66M
--568.73K
--213.66K
838.57%3M
--174.27K
----
----
110.30%319.69K
Asset deal income
----
----
----
----
----
----
----
----
----
---241.71K
Other revenue
-47.58%344.81K
-39.85%2.53M
-44.19%1.23M
-54.49%979.47K
-38.45%657.76K
-16.79%4.2M
-23.80%2.2M
8.82%2.15M
255.81%1.07M
-41.03%5.05M
Operating profit
-7.50%33.13M
10.42%156.85M
0.55%102.19M
4.23%70.23M
-8.40%35.81M
16.46%142.05M
21.95%101.63M
27.12%67.37M
34.91%39.1M
0.27%121.97M
Add:Non operating Income
-64.05%180.19K
-52.40%584.79K
801.06%571.27K
805.40%566.79K
724.29%501.17K
13,960.07%1.23M
856.46%63.4K
946.21%62.6K
974.10%60.8K
-99.78%8.74K
Less:Non operating expense
20.90%151.15K
-54.78%673.27K
-72.32%397.45K
-31.31%298.55K
-52.00%125.02K
13.81%1.49M
203.90%1.44M
70.67%434.65K
196.84%260.46K
-29.89%1.31M
Total profit
-8.38%33.15M
10.56%156.76M
2.10%102.37M
5.21%70.49M
-6.97%36.19M
17.49%141.79M
20.98%100.26M
27.01%67M
34.60%38.9M
-2.51%120.68M
Less:Income tax cost
-14.68%4.25M
8.58%20.88M
6.38%14.16M
8.26%9.7M
-9.75%4.98M
20.11%19.23M
21.56%13.31M
29.05%8.96M
41.34%5.51M
-1.13%16.01M
Net profit
-7.38%28.91M
10.87%135.88M
1.45%88.21M
4.74%60.79M
-6.51%31.21M
17.09%122.56M
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
Net profit from continuing operation
-7.38%28.91M
10.87%135.88M
1.45%88.21M
4.74%60.79M
-6.51%31.21M
17.09%122.56M
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
Net profit of parent company owners
-7.38%28.91M
10.87%135.88M
1.45%88.21M
4.74%60.79M
-6.51%31.21M
17.09%122.56M
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
Earning per share
Basic earning per share
-9.52%0.19
10.98%0.91
1.72%0.59
5.13%0.41
-36.36%0.21
-27.43%0.82
-27.50%0.58
-29.09%0.39
-32.65%0.33
-46.45%1.13
Diluted earning per share
-5.00%0.19
8.54%0.89
0.00%0.58
2.56%0.4
-39.39%0.2
-27.43%0.82
-27.50%0.58
-29.09%0.39
-32.65%0.33
-46.45%1.13
Other composite income
Total composite income
-7.38%28.91M
10.87%135.88M
1.45%88.21M
4.74%60.79M
-6.51%31.21M
17.09%122.56M
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
Total composite income of parent company owners
-7.38%28.91M
10.87%135.88M
1.45%88.21M
4.74%60.79M
-6.51%31.21M
17.09%122.56M
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -9.53%107.19M12.88%532.26M12.13%358.87M14.93%242.09M2.32%118.48M18.63%471.51M13.02%320.04M8.93%210.64M8.27%115.8M-5.99%397.45M
Operating revenue -9.53%107.19M12.88%532.26M12.13%358.87M14.93%242.09M2.32%118.48M18.63%471.51M13.02%320.04M8.93%210.64M8.27%115.8M-5.99%397.45M
Other operating revenue -----39.12%587.92K-----5.82%407.79K-----17.36%965.74K-----53.80%432.99K-----28.82%1.17M
Total operating cost -7.92%76.95M14.47%381.2M17.47%259.59M18.86%172.7M7.96%83.57M19.91%333.03M9.41%220.99M3.15%145.3M-0.08%77.41M-8.61%277.74M
Operating cost -15.97%55.54M4.92%289.55M4.07%195.28M8.00%134.3M-6.26%66.1M17.84%275.96M10.57%187.65M5.40%124.36M4.66%70.51M-11.57%234.18M
Operating tax surcharges 33.94%1.36M5.08%4.58M7.65%3.6M2.81%2.32M13.61%1.01M4.75%4.36M16.24%3.35M7.46%2.25M17.00%892.61K95.38%4.16M
Operating expense 11.60%2.86M31.17%16.2M28.98%11.18M12.18%6.74M49.46%2.56M18.06%12.35M8.26%8.67M14.19%6M-10.76%1.71M4.22%10.46M
Administration expense 3.70%7.27M20.60%37.03M41.09%25.68M29.34%15.49M38.25%7.01M17.96%30.71M-9.05%18.2M-13.62%11.98M5.29%5.07M14.53%26.03M
Financial expense 120.56%525.26K72.31%-5.02M70.66%-4.31M64.60%-3.85M49.55%-2.55M-13.74%-18.13M-33.27%-14.69M-76.41%-10.88M-1,133.71%-5.06M-37.70%-15.94M
-Interest expense (Financial expense) -9.69%76.7K-7.40%346.05K-7.15%259.16K-6.36%172.79K-7.94%84.93K1,000.55%373.72K986.72%279.12K467.99%184.52K467.99%92.26K-49.99%33.96K
-Interest Income (Financial expense) 50.69%-946.11K63.13%-5.68M69.90%-4M66.44%-3.08M53.40%-1.92M-0.75%-15.41M-32.28%-13.28M-68.25%-9.17M-213.59%-4.12M-330.91%-15.3M
Research and development -0.43%9.4M39.89%38.86M57.96%28.17M52.83%17.71M120.63%9.44M47.44%27.78M43.61%17.83M48.10%11.59M42.58%4.28M19.50%18.84M
Credit Impairment Loss 2,840.98%1.33M-2,610.71%-2.75M-170.86%-566.72K-205.41%-448.21K182.19%45.09K76.25%-101.55K50,837.53%799.76K151.35%425.21K90.25%-54.86K44.38%-427.52K
Asset Impairment Loss -341.27%-60.71K80.24%-698.85K32.50%-400.2K52.91%-256.9K95.52%-13.76K-45.07%-3.54M-21.81%-592.85K-32.50%-545.51K---306.99K-107.81%-2.44M
Other net revenue 219.42%2.88M62.49%5.79M13.28%2.92M-58.51%843.08K27.71%902.75K57.62%3.56M19.76%2.58M309.42%2.03M240.24%706.85K-18.50%2.26M
Fair value change income ------1.7M--------------------------------
Invest income 496.04%1.27M67.23%5.02M1,426.94%2.66M--568.73K--213.66K838.57%3M--174.27K--------110.30%319.69K
Asset deal income ---------------------------------------241.71K
Other revenue -47.58%344.81K-39.85%2.53M-44.19%1.23M-54.49%979.47K-38.45%657.76K-16.79%4.2M-23.80%2.2M8.82%2.15M255.81%1.07M-41.03%5.05M
Operating profit -7.50%33.13M10.42%156.85M0.55%102.19M4.23%70.23M-8.40%35.81M16.46%142.05M21.95%101.63M27.12%67.37M34.91%39.1M0.27%121.97M
Add:Non operating Income -64.05%180.19K-52.40%584.79K801.06%571.27K805.40%566.79K724.29%501.17K13,960.07%1.23M856.46%63.4K946.21%62.6K974.10%60.8K-99.78%8.74K
Less:Non operating expense 20.90%151.15K-54.78%673.27K-72.32%397.45K-31.31%298.55K-52.00%125.02K13.81%1.49M203.90%1.44M70.67%434.65K196.84%260.46K-29.89%1.31M
Total profit -8.38%33.15M10.56%156.76M2.10%102.37M5.21%70.49M-6.97%36.19M17.49%141.79M20.98%100.26M27.01%67M34.60%38.9M-2.51%120.68M
Less:Income tax cost -14.68%4.25M8.58%20.88M6.38%14.16M8.26%9.7M-9.75%4.98M20.11%19.23M21.56%13.31M29.05%8.96M41.34%5.51M-1.13%16.01M
Net profit -7.38%28.91M10.87%135.88M1.45%88.21M4.74%60.79M-6.51%31.21M17.09%122.56M20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M
Net profit from continuing operation -7.38%28.91M10.87%135.88M1.45%88.21M4.74%60.79M-6.51%31.21M17.09%122.56M20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M
Net profit of parent company owners -7.38%28.91M10.87%135.88M1.45%88.21M4.74%60.79M-6.51%31.21M17.09%122.56M20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M
Earning per share
Basic earning per share -9.52%0.1910.98%0.911.72%0.595.13%0.41-36.36%0.21-27.43%0.82-27.50%0.58-29.09%0.39-32.65%0.33-46.45%1.13
Diluted earning per share -5.00%0.198.54%0.890.00%0.582.56%0.4-39.39%0.2-27.43%0.82-27.50%0.58-29.09%0.39-32.65%0.33-46.45%1.13
Other composite income
Total composite income -7.38%28.91M10.87%135.88M1.45%88.21M4.74%60.79M-6.51%31.21M17.09%122.56M20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M
Total composite income of parent company owners -7.38%28.91M10.87%135.88M1.45%88.21M4.74%60.79M-6.51%31.21M17.09%122.56M20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More